Effect of Testosterone on Natriuretic Peptide Levels

Katherine N. Bachmann, Shi Huang, Hang Lee, Laura E. Dichtel, Deepak K. Gupta, John C Jr. Burnett, Karen K. Miller, Thomas J. Wang, Joel S. Finkelstein

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Circulating natriuretic peptide (NP) levels are markedly lower in healthy men than women. A relative NP deficiency in men could contribute to their higher risk of hypertension and cardiovascular disease. Epidemiological studies suggest testosterone may contribute to sex-specific NP differences. Objectives: This study aimed to determine the effect of testosterone administration on NP levels using a randomized, placebo-controlled design. Methods: One hundred and fifty-one healthy men (20 to 50 years of age) received goserelin acetate to suppress endogenous production of gonadal steroids, and anastrazole to suppress conversion of testosterone to estradiol. Subjects were randomized to placebo gel or 4 different doses of testosterone (1%) gel for 12 weeks. Serum N-terminal-pro–B-type natriuretic peptide (NT-proBNP) and total testosterone levels were measured at baseline and follow-up. Results: Men who did not receive testosterone replacement (placebo gel group) after suppression of endogenous gonadal steroid production experienced a profound decrease in serum testosterone (median 540 to 36 ng/dl; p < 0.0001). This was accompanied by an increase in median NT-proBNP (+8 pg/ml; p = 0.02). Each 1-g increase in testosterone dose was associated with a 4.3% lower NT-proBNP at follow-up (95% confidence interval: −7.9% to −0.45%; p = 0.029). An individual whose serum testosterone decreased by 500 ng/dl had a 26% higher predicted follow-up NT-proBNP than someone whose serum testosterone remained constant. Conclusions: Suppression of testosterone production in men led to increases in circulating NT-proBNP, which were attenuated by testosterone replacement. Inhibition of NP production by testosterone may partly explain the lower NP levels in men. (Dose-Response of Gonadal Steroids and Bone Turnover in Men; NCT00114114)

Original languageEnglish (US)
Pages (from-to)1288-1296
Number of pages9
JournalJournal of the American College of Cardiology
Volume73
Issue number11
DOIs
StatePublished - Mar 26 2019

Fingerprint

Natriuretic Peptides
Testosterone
Gels
Steroids
Placebos
Serum
Goserelin
Bone Remodeling
Epidemiologic Studies
Estradiol
Cardiovascular Diseases

Keywords

  • BNP
  • cardiovascular risk
  • hypertension
  • natriuretic peptide
  • NT-proBNP
  • testosterone

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Bachmann, K. N., Huang, S., Lee, H., Dichtel, L. E., Gupta, D. K., Burnett, J. C. J., ... Finkelstein, J. S. (2019). Effect of Testosterone on Natriuretic Peptide Levels. Journal of the American College of Cardiology, 73(11), 1288-1296. https://doi.org/10.1016/j.jacc.2018.12.062

Effect of Testosterone on Natriuretic Peptide Levels. / Bachmann, Katherine N.; Huang, Shi; Lee, Hang; Dichtel, Laura E.; Gupta, Deepak K.; Burnett, John C Jr.; Miller, Karen K.; Wang, Thomas J.; Finkelstein, Joel S.

In: Journal of the American College of Cardiology, Vol. 73, No. 11, 26.03.2019, p. 1288-1296.

Research output: Contribution to journalArticle

Bachmann, KN, Huang, S, Lee, H, Dichtel, LE, Gupta, DK, Burnett, JCJ, Miller, KK, Wang, TJ & Finkelstein, JS 2019, 'Effect of Testosterone on Natriuretic Peptide Levels', Journal of the American College of Cardiology, vol. 73, no. 11, pp. 1288-1296. https://doi.org/10.1016/j.jacc.2018.12.062
Bachmann, Katherine N. ; Huang, Shi ; Lee, Hang ; Dichtel, Laura E. ; Gupta, Deepak K. ; Burnett, John C Jr. ; Miller, Karen K. ; Wang, Thomas J. ; Finkelstein, Joel S. / Effect of Testosterone on Natriuretic Peptide Levels. In: Journal of the American College of Cardiology. 2019 ; Vol. 73, No. 11. pp. 1288-1296.
@article{fbe592d7684d4538ba314557876d838c,
title = "Effect of Testosterone on Natriuretic Peptide Levels",
abstract = "Background: Circulating natriuretic peptide (NP) levels are markedly lower in healthy men than women. A relative NP deficiency in men could contribute to their higher risk of hypertension and cardiovascular disease. Epidemiological studies suggest testosterone may contribute to sex-specific NP differences. Objectives: This study aimed to determine the effect of testosterone administration on NP levels using a randomized, placebo-controlled design. Methods: One hundred and fifty-one healthy men (20 to 50 years of age) received goserelin acetate to suppress endogenous production of gonadal steroids, and anastrazole to suppress conversion of testosterone to estradiol. Subjects were randomized to placebo gel or 4 different doses of testosterone (1{\%}) gel for 12 weeks. Serum N-terminal-pro–B-type natriuretic peptide (NT-proBNP) and total testosterone levels were measured at baseline and follow-up. Results: Men who did not receive testosterone replacement (placebo gel group) after suppression of endogenous gonadal steroid production experienced a profound decrease in serum testosterone (median 540 to 36 ng/dl; p < 0.0001). This was accompanied by an increase in median NT-proBNP (+8 pg/ml; p = 0.02). Each 1-g increase in testosterone dose was associated with a 4.3{\%} lower NT-proBNP at follow-up (95{\%} confidence interval: −7.9{\%} to −0.45{\%}; p = 0.029). An individual whose serum testosterone decreased by 500 ng/dl had a 26{\%} higher predicted follow-up NT-proBNP than someone whose serum testosterone remained constant. Conclusions: Suppression of testosterone production in men led to increases in circulating NT-proBNP, which were attenuated by testosterone replacement. Inhibition of NP production by testosterone may partly explain the lower NP levels in men. (Dose-Response of Gonadal Steroids and Bone Turnover in Men; NCT00114114)",
keywords = "BNP, cardiovascular risk, hypertension, natriuretic peptide, NT-proBNP, testosterone",
author = "Bachmann, {Katherine N.} and Shi Huang and Hang Lee and Dichtel, {Laura E.} and Gupta, {Deepak K.} and Burnett, {John C Jr.} and Miller, {Karen K.} and Wang, {Thomas J.} and Finkelstein, {Joel S.}",
year = "2019",
month = "3",
day = "26",
doi = "10.1016/j.jacc.2018.12.062",
language = "English (US)",
volume = "73",
pages = "1288--1296",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "11",

}

TY - JOUR

T1 - Effect of Testosterone on Natriuretic Peptide Levels

AU - Bachmann, Katherine N.

AU - Huang, Shi

AU - Lee, Hang

AU - Dichtel, Laura E.

AU - Gupta, Deepak K.

AU - Burnett, John C Jr.

AU - Miller, Karen K.

AU - Wang, Thomas J.

AU - Finkelstein, Joel S.

PY - 2019/3/26

Y1 - 2019/3/26

N2 - Background: Circulating natriuretic peptide (NP) levels are markedly lower in healthy men than women. A relative NP deficiency in men could contribute to their higher risk of hypertension and cardiovascular disease. Epidemiological studies suggest testosterone may contribute to sex-specific NP differences. Objectives: This study aimed to determine the effect of testosterone administration on NP levels using a randomized, placebo-controlled design. Methods: One hundred and fifty-one healthy men (20 to 50 years of age) received goserelin acetate to suppress endogenous production of gonadal steroids, and anastrazole to suppress conversion of testosterone to estradiol. Subjects were randomized to placebo gel or 4 different doses of testosterone (1%) gel for 12 weeks. Serum N-terminal-pro–B-type natriuretic peptide (NT-proBNP) and total testosterone levels were measured at baseline and follow-up. Results: Men who did not receive testosterone replacement (placebo gel group) after suppression of endogenous gonadal steroid production experienced a profound decrease in serum testosterone (median 540 to 36 ng/dl; p < 0.0001). This was accompanied by an increase in median NT-proBNP (+8 pg/ml; p = 0.02). Each 1-g increase in testosterone dose was associated with a 4.3% lower NT-proBNP at follow-up (95% confidence interval: −7.9% to −0.45%; p = 0.029). An individual whose serum testosterone decreased by 500 ng/dl had a 26% higher predicted follow-up NT-proBNP than someone whose serum testosterone remained constant. Conclusions: Suppression of testosterone production in men led to increases in circulating NT-proBNP, which were attenuated by testosterone replacement. Inhibition of NP production by testosterone may partly explain the lower NP levels in men. (Dose-Response of Gonadal Steroids and Bone Turnover in Men; NCT00114114)

AB - Background: Circulating natriuretic peptide (NP) levels are markedly lower in healthy men than women. A relative NP deficiency in men could contribute to their higher risk of hypertension and cardiovascular disease. Epidemiological studies suggest testosterone may contribute to sex-specific NP differences. Objectives: This study aimed to determine the effect of testosterone administration on NP levels using a randomized, placebo-controlled design. Methods: One hundred and fifty-one healthy men (20 to 50 years of age) received goserelin acetate to suppress endogenous production of gonadal steroids, and anastrazole to suppress conversion of testosterone to estradiol. Subjects were randomized to placebo gel or 4 different doses of testosterone (1%) gel for 12 weeks. Serum N-terminal-pro–B-type natriuretic peptide (NT-proBNP) and total testosterone levels were measured at baseline and follow-up. Results: Men who did not receive testosterone replacement (placebo gel group) after suppression of endogenous gonadal steroid production experienced a profound decrease in serum testosterone (median 540 to 36 ng/dl; p < 0.0001). This was accompanied by an increase in median NT-proBNP (+8 pg/ml; p = 0.02). Each 1-g increase in testosterone dose was associated with a 4.3% lower NT-proBNP at follow-up (95% confidence interval: −7.9% to −0.45%; p = 0.029). An individual whose serum testosterone decreased by 500 ng/dl had a 26% higher predicted follow-up NT-proBNP than someone whose serum testosterone remained constant. Conclusions: Suppression of testosterone production in men led to increases in circulating NT-proBNP, which were attenuated by testosterone replacement. Inhibition of NP production by testosterone may partly explain the lower NP levels in men. (Dose-Response of Gonadal Steroids and Bone Turnover in Men; NCT00114114)

KW - BNP

KW - cardiovascular risk

KW - hypertension

KW - natriuretic peptide

KW - NT-proBNP

KW - testosterone

UR - http://www.scopus.com/inward/record.url?scp=85062807937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062807937&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2018.12.062

DO - 10.1016/j.jacc.2018.12.062

M3 - Article

C2 - 30898204

AN - SCOPUS:85062807937

VL - 73

SP - 1288

EP - 1296

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 11

ER -